Subsequent bioactivity research revealed that compound 1 triggered apoptosis in T24 cells (urinary bladder cancer) by modifying anti- and pro-apoptotic proteins, resulting in mitochondrial malfunction and the activation of caspase-3, ultimately leading to cell demise. This evidence concerns the gene CASP3 and urinary bladder cancer.